The same authors reported the frequent detection of TP53 mutations in MDS-del(5q) with isolated 5q abnormality, negative for TP53 mutations at diagnosis and treated with lenalidomide (6 out of 15 patients) [92]. This evidence concerns the gene TP53 and myelodysplastic syndrome.